Company Introduction

ADEISS is a leader in the provision of customized and patient-specific medical devices to the Canadian market through additive manufacturing. As an ISO 13485 compliant company holding a Medical Device Establishment License (MDEL), ADEISS works with leading researchers and clinicians to design, develop and 3D-print metal-based implants and surgical instruments for use in the orthopaedic, dental, and veterinary markets. The ADEISS team is now seeking investment support to help scale operations and expand market reach.

Brief description of main products or services 

ADEISS is uniquely set up as a hybrid medical manufacturer, providing medical 3D-printing services and medical device product lines. For contract 3D-printing services, ADEISS additively manufactures parts based on customer-provided designs. ADEISS’s current revenue from contract 3D-printing services is approximately $50,000 CDN annually. Independent of contract 3D-printing services, ADEISS has two active products in development.

ADEISS’s first product line, and the closest to market release, is the custom implants for craniomaxillofacial applications. The custom craniomaxillofacial implant global market is poised to reach USD 266.2 million by 2022. Custom implants are a novelty within the medical industry due to the full suite of expertise provided with the product; custom device design specific to the surgical need, custom 3D-printed medical device/s to match an individual patient, and quick turnaround time.

ADEISS’s second product line is spinal fusion cages for posterior lumbar intervertebral fusion (PLIF). This product was developed in collaboration with expert spinal surgeons and tailored to meet industry needs. The PLIF device global market was projected to reach USD 1069.1 million by 2021. ADEISS is already expected to secure $300,000 CDN within the first year of product release, based on requests from local hospitals in the London Ontario region.